OCP-TAP approves Adtran’s OSA 5400 TimeCard™ for precise, resilient data center timing
28.9.2023 15:00:00 EEST | Business Wire | Press release
Adtran today announced that the Open Compute Project (OCP) Time Appliance Project (TAP) has approved its OSA 5400 TimeCard™ for data center timing and synchronization. The pluggable device injects Adtran’s Oscilloquartz timing technology into any white box server, solving key challenges in the transition to virtualized environments. The OCP-TAP’s endorsement means data center operators leveraging the OSA 5400 TimeCard™ to synchronize COTS hardware can be assured of precise, reliable and robust timing as they move to more cost-efficient and scalable network architectures.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230928894327/en/
The OSA 5400 TimeCard™ represents a simple route to accurate, reliable and robust data center timing. (Photo: Business Wire)
“We’re pleased to be able to announce that Adtran’s OSA 5400 TimeCard™ now supports the OCP-TAP driver. It’s an important milestone in our collective quest to advance robust and accurate timing solutions for distributed system use cases. By meeting our framework’s specifications, Adtran is helping us drive standardization and interoperability, accelerating the industry’s shift to open, standardized hardware,” said Ahmad Byagowi, TAP project leader at OCP-TAP. “This pluggable solution represents a simple route to accurate, reliable and robust data center timing. We believe that solutions like the OSA 5400 TimeCard™ will play a pivotal role in advancing the next generation of scalable and resilient infrastructure.”
Enabling data center operators to efficiently host the most demanding time-sensitive applications, Adtran’s OSA 5400 TimeCard™ plugs into any free PCIe slot to turn a standard COTS server into a precise PTP grandmaster clock or NTP server. With multiple oscillator options, the solution ensures accurate timing even during extended periods of GNSS disturbances. In combination with Adtran’s Ensemble Sync Director, the OSA 5400 TimeCard™ provides operational teams with a comprehensive, unified view of their entire timing infrastructure. This enables them to easily manage all elements of their timing network, enhancing control and reliability. What’s more, the OSA 5400 TimeCard™ has been developed to align fully with the IEEE P3335 standardization, ensuring adaptability and underscoring Adtran’s commitment to industry advancement in a cohesive digital ecosystem.
“We’re proud that our OSA 5400 TimeCard™ has been validated by OCP-TAP. This card brings our 74 years of expertise in timing and synchronization to standard servers, going beyond the TAP specifications to provide a scalable, fully featured timing solution in a compact half-size PCIe card. It offers a major boost for data center operators looking to embrace open, disaggregated hardware, especially where timing is vital and space is limited. Our OSA 5400 TimeCard™ ensures seamless, efficient operation of mission-critical and time-sensitive applications,” commented Igal Pinhasov, VP of PLM at Oscilloquartz, Adtran. “As the industry progresses towards agile, cost-effective data center environments, our pluggable timing technology will play a defining role in shaping future architectures.”
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and Twitter.
Published by
ADTRAN Holdings, Inc.
www.adtran.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230928894327/en/
Contact information
For media
Gareth Spence
+44 1904 699 358
public-relations@adva.com
For investors
Steven Williams
+49 89 890 665 918
investor@adtran.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
